DANAY MARANTE: Open Payments
NPI 1811418205 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 13 payments from 7 companies in 2025. Trend: 2023 $1,031 · 2024 $774 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 3 | $81 |
| ABBVIE INC. | 2 | $44 |
| Lundbeck LLC | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: REXULTI, INGREZZA, VRAYLAR, AUSTEDO XR, TRINTELLIX, COBENFY.
Industry payments across FL — which companies pay providers there.
